SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $713 | -99.9% | 5,510 | -49.3% | 0.14% | +47.8% |
Q1 2022 | $848,000 | -6.7% | 10,860 | +7.5% | 0.09% | -28.1% |
Q4 2021 | $909,000 | -47.3% | 10,101 | -56.4% | 0.13% | -12.3% |
Q1 2021 | $1,726,000 | -76.6% | 23,171 | -46.4% | 0.15% | -75.5% |
Q4 2020 | $7,367,000 | +3188.8% | 43,215 | +1787.1% | 0.60% | +2387.5% |
Q1 2020 | $224,000 | -97.8% | 2,290 | -96.6% | 0.02% | -94.0% |
Q2 2019 | $10,363,000 | -3.2% | 68,203 | -52.8% | 0.40% | +116.1% |
Q1 2018 | $10,706,000 | +185.5% | 144,500 | +114.4% | 0.19% | +238.2% |
Q4 2017 | $3,750,000 | -72.8% | 67,400 | -77.8% | 0.06% | -65.0% |
Q3 2017 | $13,793,000 | +165.0% | 304,100 | +97.0% | 0.16% | +101.3% |
Q2 2017 | $5,204,000 | -3.9% | 154,400 | -21.8% | 0.08% | -42.6% |
Q4 2016 | $5,414,000 | +69.2% | 197,400 | +17.6% | 0.14% | -8.7% |
Q2 2016 | $3,199,000 | +628.7% | 167,800 | +1371.9% | 0.15% | +451.9% |
Q4 2015 | $439,000 | -21.3% | 11,400 | -34.5% | 0.03% | -35.7% |
Q3 2015 | $558,000 | +121.4% | 17,400 | +109.6% | 0.04% | +10.5% |
Q2 2015 | $252,000 | -68.0% | 8,300 | -50.3% | 0.04% | -45.7% |
Q3 2013 | $788,000 | +264.8% | 16,700 | +193.0% | 0.07% | +84.2% |
Q2 2013 | $216,000 | – | 5,700 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |